drugset / Trial / NCT01643070

Preoperative CRT With or Without Induction Chemotherapy for Rectal Cancer With Liver Metastases

NCT01643070 ↗

Phase 2 Completed 38 enrolled Asan Medical Center
RandomizedFactorialOpen-labelTreatment

Summary

To investigate the feasibility of preoperative chemoradiation with oxaliplatin plus capecitabine, with or without prior induction chemotherapy in patients with locally advanced or marginally resectable rectal cancer with resectable synchronous liver metastases.

Timeline

Start
2010-01
Primary completion
2014-09
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Capecitabine Small molecule 825 mg/m2 Oral
Comparator Capecitabine Small molecule 1250 mg/m2 Oral
Comparator Oxaliplatin Small molecule 50 mg/m2 —
Comparator Oxaliplatin Small molecule 130 mg/m2 —